Stocks and Investing Stocks and Investing
Mon, March 4, 2019
Fri, March 1, 2019

Geoff Meacham Maintained (UTHR) at Sell with Decreased Target to $95 on, Mar 1st, 2019


Published on 2024-10-26 12:25:29 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Maintained "United Therapeutics Corporation" (UTHR) at Sell with Decreased Target from $100 to $95 on, Mar 1st, 2019.

Geoff has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jessica Fye of "JP Morgan" Maintained at Hold with Increased Target to $126 on, Friday, November 2nd, 2018


This is the rating of the analyst that currently disagrees with Geoff


  • M. Auster of "Credit Suisse" Maintained at Sell with Increased Target to $105 on, Monday, November 19th, 2018

Contributing Sources